Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001477932-25-004313
Filing Date
2025-06-02
Accepted
2025-06-02 17:11:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFR 14A upxi_defr14a.htm DEFR14A 654904
2 upxi_pre14aimg3.jpg GRAPHIC 171435
3 upxi_pre14aimg4.jpg GRAPHIC 125107
  Complete submission text file 0001477932-25-004313.txt   1064667
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFR14A | Act: 34 | File No.: 001-40535 | Film No.: 251016058
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)